P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study

Detalhes bibliográficos
Autor(a) principal: Júnior, Luiz Antonio Lupi
Data de Publicação: 2019
Outros Autores: Cucielo, Maira Smaniotto, Domeniconi, Raquel Fantin, Dos Santos, Lucilene Delazari [UNESP], Silveira, Henrique Spaulonci, Da Silva Nunes, Iseu, Martinez, Marcelo, Martinez, Francisco Eduardo, Fávaro, Wagner José, Chuffa, Luiz Gustavo De Almeida
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1021/acsomega.9b02512
http://hdl.handle.net/11449/199836
Resumo: To investigate the potential role of immunotherapies in the cellular and molecular mechanisms associated with ovarian cancer (OC), we applied a comparative proteomic toll using protein identification combined with mass spectrometry. Herein, the effects of the protein aggregate magnesium-ammonium phospholinoleate-palmitoleate anhydride, known as P-MAPA, and the human recombinant interleukin-12 (hrIL-12) were tested alone or in combination in human SKOV-3 cells. The doses and period were defined based on a previous study, which showed that 25 μg/mL P-MAPA and 1 ng/mL IL-12 are sufficient to reduce cell metabolism after 48 h. Indeed, among 2,881 proteins modulated by the treatments, 532 of them were strictly concordant and common. P-MAPA therapy upregulated proteins involved in tight junction, focal adhesion, ribosome constitution, GTP hydrolysis, semaphorin interactions, and expression of SLIT and ROBO, whereas it downregulated ERBB4 signaling, toll-like receptor signaling, regulation of NOTCH 4, and the ubiquitin proteasome pathway. In addition, IL-12 therapy led to upregulation of leukocyte migration, tight junction, and cell signaling, while cell communication, cell metabolism, and Wnt signaling were significantly downregulated in OC cells. A clear majority of proteins that were overexpressed by the combination of P-MAPA with IL-12 are involved in tight junction, focal adhesion, DNA methylation, metabolism of RNA, and ribosomal function; only a small number of downregulated proteins were involved in cell signaling, energy and mitochondrial processes, cell oxidation and senescence, and Wnt signaling. These findings suggest that P-MAPA and IL-12 efficiently regulated important proteins associated with OC progression; these altered proteins may represent potential targets for OC treatment in addition to its immunoadjuvant effects.
id UNSP_61bded4cd06f62215a992e1daf165b8b
oai_identifier_str oai:repositorio.unesp.br:11449/199836
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic StudyTo investigate the potential role of immunotherapies in the cellular and molecular mechanisms associated with ovarian cancer (OC), we applied a comparative proteomic toll using protein identification combined with mass spectrometry. Herein, the effects of the protein aggregate magnesium-ammonium phospholinoleate-palmitoleate anhydride, known as P-MAPA, and the human recombinant interleukin-12 (hrIL-12) were tested alone or in combination in human SKOV-3 cells. The doses and period were defined based on a previous study, which showed that 25 μg/mL P-MAPA and 1 ng/mL IL-12 are sufficient to reduce cell metabolism after 48 h. Indeed, among 2,881 proteins modulated by the treatments, 532 of them were strictly concordant and common. P-MAPA therapy upregulated proteins involved in tight junction, focal adhesion, ribosome constitution, GTP hydrolysis, semaphorin interactions, and expression of SLIT and ROBO, whereas it downregulated ERBB4 signaling, toll-like receptor signaling, regulation of NOTCH 4, and the ubiquitin proteasome pathway. In addition, IL-12 therapy led to upregulation of leukocyte migration, tight junction, and cell signaling, while cell communication, cell metabolism, and Wnt signaling were significantly downregulated in OC cells. A clear majority of proteins that were overexpressed by the combination of P-MAPA with IL-12 are involved in tight junction, focal adhesion, DNA methylation, metabolism of RNA, and ribosomal function; only a small number of downregulated proteins were involved in cell signaling, energy and mitochondrial processes, cell oxidation and senescence, and Wnt signaling. These findings suggest that P-MAPA and IL-12 efficiently regulated important proteins associated with OC progression; these altered proteins may represent potential targets for OC treatment in addition to its immunoadjuvant effects.Department of Anatomy Institute of BiosciencesCenter for the Study of Venoms and Venomous Animals (CEVAP) UNESP - Universidade Estadual PaulistaFarmabrasilis RandD DivisionDepartment of Structural and Functional Biology UNICAMP - University of CampinasDepartment of Morphology and Pathology Federal University of São CarlosCenter for the Study of Venoms and Venomous Animals (CEVAP) UNESP - Universidade Estadual PaulistaUniversidade Estadual Paulista (Unesp)Farmabrasilis RandD DivisionUniversidade Estadual de Campinas (UNICAMP)Universidade Federal de São Carlos (UFSCar)Júnior, Luiz Antonio LupiCucielo, Maira SmaniottoDomeniconi, Raquel FantinDos Santos, Lucilene Delazari [UNESP]Silveira, Henrique SpaulonciDa Silva Nunes, IseuMartinez, MarceloMartinez, Francisco EduardoFávaro, Wagner JoséChuffa, Luiz Gustavo De Almeida2020-12-12T01:50:36Z2020-12-12T01:50:36Z2019-12-24info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article21761-21777http://dx.doi.org/10.1021/acsomega.9b02512ACS Omega, v. 4, n. 26, p. 21761-21777, 2019.2470-1343http://hdl.handle.net/11449/19983610.1021/acsomega.9b025122-s2.0-8507677051654817565282994690000-0003-2938-010XScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengACS Omegainfo:eu-repo/semantics/openAccess2024-04-11T15:28:26Zoai:repositorio.unesp.br:11449/199836Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-04-11T15:28:26Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
title P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
spellingShingle P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
Júnior, Luiz Antonio Lupi
title_short P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
title_full P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
title_fullStr P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
title_full_unstemmed P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
title_sort P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
author Júnior, Luiz Antonio Lupi
author_facet Júnior, Luiz Antonio Lupi
Cucielo, Maira Smaniotto
Domeniconi, Raquel Fantin
Dos Santos, Lucilene Delazari [UNESP]
Silveira, Henrique Spaulonci
Da Silva Nunes, Iseu
Martinez, Marcelo
Martinez, Francisco Eduardo
Fávaro, Wagner José
Chuffa, Luiz Gustavo De Almeida
author_role author
author2 Cucielo, Maira Smaniotto
Domeniconi, Raquel Fantin
Dos Santos, Lucilene Delazari [UNESP]
Silveira, Henrique Spaulonci
Da Silva Nunes, Iseu
Martinez, Marcelo
Martinez, Francisco Eduardo
Fávaro, Wagner José
Chuffa, Luiz Gustavo De Almeida
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Farmabrasilis RandD Division
Universidade Estadual de Campinas (UNICAMP)
Universidade Federal de São Carlos (UFSCar)
dc.contributor.author.fl_str_mv Júnior, Luiz Antonio Lupi
Cucielo, Maira Smaniotto
Domeniconi, Raquel Fantin
Dos Santos, Lucilene Delazari [UNESP]
Silveira, Henrique Spaulonci
Da Silva Nunes, Iseu
Martinez, Marcelo
Martinez, Francisco Eduardo
Fávaro, Wagner José
Chuffa, Luiz Gustavo De Almeida
description To investigate the potential role of immunotherapies in the cellular and molecular mechanisms associated with ovarian cancer (OC), we applied a comparative proteomic toll using protein identification combined with mass spectrometry. Herein, the effects of the protein aggregate magnesium-ammonium phospholinoleate-palmitoleate anhydride, known as P-MAPA, and the human recombinant interleukin-12 (hrIL-12) were tested alone or in combination in human SKOV-3 cells. The doses and period were defined based on a previous study, which showed that 25 μg/mL P-MAPA and 1 ng/mL IL-12 are sufficient to reduce cell metabolism after 48 h. Indeed, among 2,881 proteins modulated by the treatments, 532 of them were strictly concordant and common. P-MAPA therapy upregulated proteins involved in tight junction, focal adhesion, ribosome constitution, GTP hydrolysis, semaphorin interactions, and expression of SLIT and ROBO, whereas it downregulated ERBB4 signaling, toll-like receptor signaling, regulation of NOTCH 4, and the ubiquitin proteasome pathway. In addition, IL-12 therapy led to upregulation of leukocyte migration, tight junction, and cell signaling, while cell communication, cell metabolism, and Wnt signaling were significantly downregulated in OC cells. A clear majority of proteins that were overexpressed by the combination of P-MAPA with IL-12 are involved in tight junction, focal adhesion, DNA methylation, metabolism of RNA, and ribosomal function; only a small number of downregulated proteins were involved in cell signaling, energy and mitochondrial processes, cell oxidation and senescence, and Wnt signaling. These findings suggest that P-MAPA and IL-12 efficiently regulated important proteins associated with OC progression; these altered proteins may represent potential targets for OC treatment in addition to its immunoadjuvant effects.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-24
2020-12-12T01:50:36Z
2020-12-12T01:50:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1021/acsomega.9b02512
ACS Omega, v. 4, n. 26, p. 21761-21777, 2019.
2470-1343
http://hdl.handle.net/11449/199836
10.1021/acsomega.9b02512
2-s2.0-85076770516
5481756528299469
0000-0003-2938-010X
url http://dx.doi.org/10.1021/acsomega.9b02512
http://hdl.handle.net/11449/199836
identifier_str_mv ACS Omega, v. 4, n. 26, p. 21761-21777, 2019.
2470-1343
10.1021/acsomega.9b02512
2-s2.0-85076770516
5481756528299469
0000-0003-2938-010X
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv ACS Omega
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 21761-21777
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1803046799626207232